Asymchem Laboratories Tianjin Co (SZSE:002821) LT-Debt-to-Total-Asset : 0.01 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Asymchem Laboratories Tianjin Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.01.

Asymchem Laboratories Tianjin Co's long-term debt to total assets ratio declined from Mar. 2023 (0.01) to Mar. 2024 (0.01). It may suggest that Asymchem Laboratories Tianjin Co is progressively becoming less dependent on debt to grow their business.

Asymchem Laboratories Tianjin Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co LT-Debt-to-Total-Asset Chart

Asymchem Laboratories Tianjin Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Asymchem Laboratories Tianjin Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Asymchem Laboratories Tianjin Co LT-Debt-to-Total-Asset Calculation

Asymchem Laboratories Tianjin Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	106.486	/	19767.159
	=	0.01

Asymchem Laboratories Tianjin Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	100.9	/	19841.423
	=	0.01

Asymchem Laboratories Tianjin Co (SZSE:002821) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Asymchem Laboratories Tianjin Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

06821:Hong Kong 7K90:Germany

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.

Executives

Xiao Yi	Executives
Xu Xiang Ke	Directors, executives
Zhou Yan	Executives
Chen Chao Yong	Executives
Huang Xiao Lian	Executives
Yang Jing	Director
	Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines